CeriBell, Inc.
CeriBell, Inc. (CBLL) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · CBLL · as of Jun 8, 2026
Key Statistics
Explore CeriBell, Inc. Data
cbll stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 4 · Buy rate: 100.0%
The CBLL analyst consensus is Buy, based on ratings from 4 Wall Street analysts over the past 3 months. The average 12-month price target is $27.50, representing +50.68% upside from the current price of $18.25.
Competitors & Peers
cbll competitorsCBLL
AUTL
BFLY
EHAB
KIDS
LABStock Performance
Full HistoryAbout CeriBell, Inc.
CeriBell, Inc. develops AI based point-of-care electroencephalography (EEG) technology for the detection and treatment of neurological conditions. The company develops Ceribell System, a novel, point-…
what is ceribell, inc. · cbll stock overview · ceribell, inc. company profile · who is ceribell, inc. ceo · cbll NASDAQ · ceribell, inc. headquarters · ceribell, inc. business segments
About Stock Overview & Key Data
CeriBell, Inc. (CBLL) is a Healthcare company in the Medical - Devices industry, listed on NASDAQ since Oct 11, 2024. As of the latest trading session, CBLL stock price is $18.25, with a market capitalization of $692.5M. The stock has returned +2.47% over the past 12 months and -16.78% year-to-date.
According to 4 Wall Street analysts, the consensus rating for CeriBell, Inc. stock is Buy, with an average 12-month price target of $27.50. In fiscal year 2025, CeriBell, Inc. reported revenue of $89.1M and net income of -$53.4M. For detailed data — including CeriBell, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, CeriBell, Inc. (CBLL) stock price is $18.25. The stock is traded on NASDAQ under the ticker symbol CBLL. The 52-week range is $10.85 – $24.33.